Trevi Therapeutics (TRVI)

Trevi Therapeutics (TRVI) stock research: performance, analysts' price targets, earnings, revenue and margins, technicals and insider trades.

• TRVI last traded at $13.62, 0.48% on the day.
• Trevi Therapeutics: market cap $1.93B, P/E -40.3, next earnings 2026-11-12.
• Over the past year TRVI returned 21.98%; year to date 8.83%.

Updated 2026-11-02 23:10 UTC